NCT06810544
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06810544
Title Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Tango Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Scottsdale RECRUITING Scottsdale Arizona 85259-5452 United States Details
Sibley Memorial Hospital RECRUITING Washington D.C. District of Columbia 20016 United States Details
Mayo Clinic Jacksonville RECRUITING Jacksonville Florida 32224 United States Details
Northwestern Memorial Hospital RECRUITING Chicago Illinois 60611-2908 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Mayo Clinic Cancer Center RECRUITING Rochester Minnesota 55905-0001 United States Details
NYU Langone Health RECRUITING New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 11065 United States Details
Ohio State University Comprehensive Cancer Center RECRUITING Columbus Ohio 43210 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field